These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 15273125)

  • 1. 1,2-dithiole-3-ones as potent inhibitors of the bacterial 3-ketoacyl acyl carrier protein synthase III (FabH).
    He X; Reeve AM; Desai UR; Kellogg GE; Reynolds KA
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3093-102. PubMed ID: 15273125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification, characterization, and identification of novel inhibitors of the beta-ketoacyl-acyl carrier protein synthase III (FabH) from Staphylococcus aureus.
    He X; Reynolds KA
    Antimicrob Agents Chemother; 2002 May; 46(5):1310-8. PubMed ID: 11959561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and antibacterial activities of vanillic acylhydrazone derivatives as potential β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
    Wang XL; Zhang YB; Tang JF; Yang YS; Chen RQ; Zhang F; Zhu HL
    Eur J Med Chem; 2012 Nov; 57():373-82. PubMed ID: 23124163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of vinylogous carbamates as a novel class of β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
    Li HQ; Luo Y; Zhu HL
    Bioorg Med Chem; 2011 Aug; 19(15):4454-9. PubMed ID: 21742506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combined approach of docking and 3D QSAR study of beta-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
    Ashek A; Cho SJ
    Bioorg Med Chem; 2006 Mar; 14(5):1474-82. PubMed ID: 16275103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, Synthesis and Antibacterial Activities of Novel Amide Derivatives Bearing Dioxygenated Rings as Potential β-Ketoacyl-acyl Carrier Protein Synthase III (FabH) Inhibitors.
    Zhou Y; Liang YQ; Wang XY; Chang HY; Hu SP; Sun J
    Chem Pharm Bull (Tokyo); 2022; 70(8):544-549. PubMed ID: 35908920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of C(7) modified chrysin derivatives designing to inhibit beta-ketoacyl-acyl carrier protein synthase III (FabH) as antibiotics.
    Li HQ; Shi L; Li QS; Liu PG; Luo Y; Zhao J; Zhu HL
    Bioorg Med Chem; 2009 Sep; 17(17):6264-9. PubMed ID: 19664929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and antibacterial activities of 5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiol derivatives containing Schiff base formation as FabH inhibitory.
    Zhang F; Wen Q; Wang SF; Shahla Karim B; Yang YS; Liu JJ; Zhang WM; Zhu HL
    Bioorg Med Chem Lett; 2014 Jan; 24(1):90-5. PubMed ID: 24332628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of the fatty acid profile of Streptomyces coelicolor by replacement of the initiation enzyme 3-ketoacyl acyl carrier protein synthase III (FabH).
    Li Y; Florova G; Reynolds KA
    J Bacteriol; 2005 Jun; 187(11):3795-9. PubMed ID: 15901703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III (FabH) as potential antibacterial agents.
    Shi L; Fang RQ; Zhu ZW; Yang Y; Cheng K; Zhong WQ; Zhu HL
    Eur J Med Chem; 2010 Sep; 45(9):4358-64. PubMed ID: 20557983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a scintillation proximity assay for beta-ketoacyl-acyl carrier protein synthase III.
    He X; Mueller JP; Reynolds KA
    Anal Biochem; 2000 Jun; 282(1):107-14. PubMed ID: 10860506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification, substrate specificity, and inhibition of the Streptococcus pneumoniae beta-ketoacyl-acyl carrier protein synthase III (FabH).
    Khandekar SS; Gentry DR; Van Aller GS; Warren P; Xiang H; Silverman C; Doyle ML; Chambers PA; Konstantinidis AK; Brandt M; Daines RA; Lonsdale JT
    J Biol Chem; 2001 Aug; 276(32):30024-30. PubMed ID: 11375394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of thiazolidine-2-one 1,1-dioxide as inhibitors of Escherichia coli beta-ketoacyl-ACP-synthase III (FabH).
    Alhamadsheh MM; Waters NC; Huddler DP; Kreishman-Deitrick M; Florova G; Reynolds KA
    Bioorg Med Chem Lett; 2007 Feb; 17(4):879-83. PubMed ID: 17189694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and biological evaluation of urea derivatives from o-hydroxybenzylamines and phenylisocyanate as potential FabH inhibitors.
    Li ZL; Li QS; Zhang HJ; Hu Y; Zhu DD; Zhu HL
    Bioorg Med Chem; 2011 Aug; 19(15):4413-20. PubMed ID: 21752655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and biological evaluation of novel thiazole derivatives as potent FabH inhibitors.
    Lv PC; Wang KR; Yang Y; Mao WJ; Chen J; Xiong J; Zhu HL
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6750-4. PubMed ID: 19836235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, Synthesis and Molecular Docking of 1,3,4-Oxadiazole-2(3H)-thione Derivatives Containing 1,4-Benzodioxane Skeleton as Potential FabH Inhibitors.
    Sun J; Zhang CP; Chen CH; Guo XM; Liu CS; Zhou Y; Hu FL
    Chem Biodivers; 2023 Feb; 20(2):e202201060. PubMed ID: 36579401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of novel deoxybenzoin derivatives as FabH inhibitors and anti-inflammatory agents.
    Li HQ; Luo Y; Lv PC; Shi L; Liu CH; Zhu HL
    Bioorg Med Chem Lett; 2010 Mar; 20(6):2025-8. PubMed ID: 20153183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of Schiff-Base-Derived with Dioxygenated Rings and Nitrogen Heterocycle as Potential β-Ketoacyl-acyl Carrier Protein Synthase III (FabH) Inhibitors.
    Zhou Y; Yang YS; Song XD; Lu L; Zhu HL
    Chem Pharm Bull (Tokyo); 2017; 65(2):178-185. PubMed ID: 28154310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antibacterial activity of cinnamaldehyde acylhydrazone with a 1,4-benzodioxan fragment as a novel class of potent β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitor.
    Song X; Yang Y; Zhao J; Chen Y
    Chem Pharm Bull (Tokyo); 2014; 62(11):1110-8. PubMed ID: 25196128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel FabH inhibitors: an updated article literature review (July 2012 to June 2013).
    Song H; Ao GZ; Li HQ
    Expert Opin Ther Pat; 2014 Jan; 24(1):19-27. PubMed ID: 24083428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.